OptimizeRx Corp OPRX
Nasdaq · XNAS · stock · Services-Business Services, NEC
Chart by TradingView
8/9
Piotroski F — financial health
3.37
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $109.4M | $5.1M | $73.6M | $18.7M | $128.3M |
| 2024 | $92.1M | -$20.1M | $59.4M | $4.8M | $117.0M |
| 2023 | $71.5M | -$17.6M | $42.9M | -$7.3M | $126.6M |
| 2023 | — | — | — | — | $115.8M |
| 2022 | $62.5M | -$11.4M | $39.0M | $10.6M | $126.1M |
| 2021 | $61.3M | $378,079 | $35.6M | $625,717 | $131.4M |
Why these scores methodology →
Piotroski F-score: 8/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.37 (safe)
- Working capital / assets 0.246
- Retained earnings / assets -0.448
- EBIT / assets 0.066
- Equity / liabilities 2.638
Source: SEC EDGAR filings · CIK 0001448431 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.